ReviewClinical & experimental metastasis1995
The role of trophic factors and autocrine/paracrine growth factors in brain metastasis.
Review in Clinical & experimental metastasis, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 54 citations in OpenAlex.
- Pathophysiological aspects of transferrin-A potential nano-based drug delivery signaling molecule in therapeutic target for varied diseases.Frontiers in pharmacology · 2024Review
- The Journey of Cancer Cells to the Brain: Challenges and Opportunities.International journal of molecular sciences · 2023Review
- Cutaneous melanoma dissemination is dependent on the malignant cell properties and factors of intercellular crosstalk in the cancer microenvironment (Review).International journal of oncology · 2020Review
- Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases.Oncotarget · 2016Review
- Article
- Role of the nervous system in cancer metastasis.Oncology letters · 2013Article
- Role of the blood-brain barrier in the formation of brain metastases.International journal of molecular sciences · 2013Review
- The biology of brain metastases-translation to new therapies.Nature reviews. Clinical oncology · 2011Review
- Decoding melanoma metastasis.Cancers · 2010Article
- Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.Clinical & experimental metastasis · 2005Article
- Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression.The American journal of pathology · 1999Article
- Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages.Clinical & experimental metastasis · 1999Article
- Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.Pathology oncology research : POR · 1997Article
- Growth factor activity of endothelin-1 in primary astrocytes mediated by adhesion-dependent and -independent pathways.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1997Article
- Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization.The Journal of cell biology · 1997Article
- Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment.Cancer metastasis reviews · 1995Review
- Trophic factors and central nervous system metastasis.Cancer metastasis reviews · 1995Review
- Solanine Attenuates Hepatocarcinoma Migration and Invasion Induced by Acetylcholine.Integrative cancer therapiesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The brain is a unique microenvironment enclosed by the skull, lacking lymphatic drainage and maintaining a highly regulated vascular transport barrier. To metastasize to the brain malignant tumor cells must attach to microvessel endothelial cells, respond to brain-derived invasion factors, invade the blood-brain barrier and respond to survival and growth factors. Trophic factors are important in brain invasion because they can act to stimulate this process. In responsive malignant cells trophic factors such as neurotrophins can promote invasion by enhancing the production of basement membrane-degradative enzymes (such as type IV collagenase/gelatinase and heparanase) capable of locally destroying the basement membrane and the blood-brain barrier. We examined human melanoma cell lines that exhibit varying abilities to form brain metastases. These melanoma lines express low-affinity neurotrophin receptor p75NTR in relation to their brain-metastatic potentials but the variants do not express trkA, the gene encoding a high affinity nerve growth factor (NGF) tyrosine kinase receptor p140trkA. Melanoma cells metastatic to brain also respond to paracrine factors made by brain cells. We have found that a paracrine form of transferrin is important in brain metastasis, and brain-metastatic cells respond to low levels of transferrin and express high levels of transferrin receptors. Brain-metastatic tumor cells can also produce autocrine factors and inhibitors that influence their growth, invasion and survival in the brain. We found that brain-metastatic melanoma cells synthesize transcripts for the following autocrine growth factors: TGF beta, bFGF, TGF alpha and IL-1 beta. Synthesis of these factors may influence the production of neurotrophins by adjacent brain cells, such as oligodendrocytes and astrocytes. Increased amounts of NGF were found in tumor-adjacent tissues at the invasion front of human melanoma tumors in brain biopsies. Trophic factors, autocrine growth factors, paracrine growth factors and other factors may determine whether metastatic cells can successfully invade, colonize and grow in the central nervous system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.